SWOT Analysis for Lilly(Eli) & Co

MACD Crossover Above Signal Line
Price crossing above SMA20 today, and greater than SMA5
Rising Momentum: Momentum Score Weekly Gainers
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Week
Stocks with Consistent Share Price Growth (subscription)
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 10 Years
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
MACD crossed above signal line previous end of day
Increasing Revenue every quarter for the past 3 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Stocks in uptrend most likely to cross above SMA-200 soon
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter

Negative Breakdown First Support (LTP < S1)
Stocks in the PE Sell Zone
PE higher than Industry PE
Companies with High Debt
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Top Losers
Negative Breakdown First Support (LTP < S1)
Companies with Increasing Debt
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV